🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PRQ
$PRQR
🔒 US EquitiesProQR Therapeutics NV
AVG HISTORICAL GAP
-0.11%
MAX GAP RECORD
+3.85%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PRQR
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PRQR
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN) |
+2.15%
|
| May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN) |
-0.62%
|
| Mar 12, 2026 Earnings Release 2026-03-12 (BEFORE OPEN) |
+0.00%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
-2.94%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
+0.00%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+3.85%
|
| Mar 12, 2025 Earnings Release 2025-03-12 (AFTER CLOSE) |
-2.16%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.1%
Bullish Gaps (4)
Bearish Gaps (6)
Neutral / Flat (1)
📖 Intelligence Summary
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗